help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueda, T.
Right arrow Articles by Jobe, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueda, T.
Right arrow Articles by Jobe, A.

Am. J. Respir. Crit. Care Med., Vol 149, No. 5, May 1994, 1254-1259.

Surfactant subtypes. In vitro conversion, in vivo function, and effects of serum proteins

T Ueda, M Ikegami and A Jobe
Department of Pediatrics, Harbor-UCLA Medical Center, University of California, Los Angeles School of Medicine, Torrance 90509.

Surfactant in the alveolar space can be separated into heavy and light subtypes by differential centrifugation or on isopyknic sucrose density gradients. The conversion from heavy subtypes to light subtypes occurs in vitro by surface-area cycling. However, the function of light subtypes made by cycling and substances that might influence in vitro conversion have not been evaluated. Therefore, we compared the in vivo function of the heavy and light subtypes isolated from rabbit surfactant and similar density fractions prepared in vitro by surface- area cycling. We then asked if serum, globulin, or albumin would alter the in vitro conversion. The function of surfactant fractions was studied in vivo by treating surfactant-deficient 27 d gestational age preterm rabbits with 50 mg/kg of heavy or light subtype surfactant. Dynamic compliance values and lung volumes from PV curve measurements showed that heavy subtypes had superior in vivo function compared with light subtypes independent of in vivo or in vitro sources (p < 0.01). Light subtypes prepared in vitro lost surfactant function and were similar to in vivo light forms. When serum proteins were added to the heavy subtype surfactant, the conversion rate from heavy to light subtypes was accelerated. Serum accelerated conversion more than globulin, and the serine proteinase inhibitor diisopropylfluorophosphate blocked the conversion. Albumin had no significant effect. The increased rate of conversion caused by serum identifies a new mechanism for surfactant inactivation that could occur with lung injuries associated with increased alveolar protein.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
I. Tsangaris, M.E. Lekka, E. Kitsiouli, S. Constantopoulos, and G. Nakos
Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury
Eur. Respir. J., March 1, 2003; 21(3): 495 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. R. Rice, J. J. Conkright, C.-L. Na, M. Ikegami, J. M. Shannon, and T. E. Weaver
Maintenance of the mouse type II cell phenotype in vitro
Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L256 - L264.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Maitra, K. Inchley, R. J. Novick, R. A. W. Veldhuizen, J. F. Lewis, and F. Possmayer
Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant
Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L67 - L74.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. J. GROSS, M. KELLAM, J. YOUNG, S. KRISHNASAMY, and R. DHAND
Separation of Alveolar Surfactant into Subtypes . A Comparison of Methods
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 617 - 622.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. M. HOHLFELD, K. AHLF, G. ENHORNING, K. BALKE, V. J. ERPENBECK, J. PETSCHALLIES, H. G. HOYMANN, H. FABEL, and N. KRUG
Dysfunction of Pulmonary Surfactant in Asthmatics after Segmental Allergen Challenge
Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1803 - 1809.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
M. Oulton, E. Edwards, and K. Handa
Convertase activity in alveolar surfactant and lamellar bodies in fetal, newborn, and adult rabbits
J Appl Physiol, January 1, 1999; 86(1): 71 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. M. HOHLFELD, E. TIRYAKI, H. HAMM, H. G. HOYMANN, N. KRUG, A. HAVERICH, and H. FABEL
Pulmonary Surfactant Activity Is Impaired in Lung Transplant Recipients
Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 706 - 712.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. Barr, H. Clark, and S. Hawgood
Identification of a putative surfactant convertase in rat lung as a secreted serine carboxylesterase
Am J Physiol Lung Cell Mol Physiol, March 1, 1998; 274(3): L404 - L410.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
K. W So, T. F Fok, P. C Ng, W. W Wong, and K. L Cheung
Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1997; 76(1): 43F - 46.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1994 American Thoracic Society